{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:53:19Z","timestamp":1785462799423,"version":"3.56.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinme.2025.100541","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:38:16Z","timestamp":1764779896000},"page":"100541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The clinical effective of sodium\/glucose co-transporter-2 inhibitors on admission frequency, duration and use of acute non-invasive ventilation in patients with chronic obstructive pulmonary disease: A single-centre 24-month retrospective observational study in a UK tertiary care centre"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-241X","authenticated-orcid":false,"given":"Alan","family":"Kan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1311-9775","authenticated-orcid":false,"given":"Joshua","family":"De Soyza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2733-4303","authenticated-orcid":false,"given":"Opeyemi","family":"Kafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranganatha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narasimha","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanth","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinme.2025.100541_bib0001","unstructured":"World Health Organization. Chronic obstructive pulmonary disease (COPD). 2024. Accessed 14 July 2025. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd)."},{"key":"10.1016\/j.clinme.2025.100541_bib0002","author":"British Lung Foundation","year":"2016","journal-title":"Estimating the Economic Burden of Respiratory Illness in the UK"},{"issue":"1","key":"10.1016\/j.clinme.2025.100541_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/srep31893","article-title":"Projecting the COPD population and costs in England and Scotland: 2011 to 2030","volume":"6","author":"McLean","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinme.2025.100541_bib0004","unstructured":"NHS England. Respiratory high impact interventions. 2022. Accessed 15 July 2025. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2022\/12\/B1590-respiratory-high-impact-interventions.pdf."},{"issue":"26","key":"10.1016\/j.clinme.2025.100541_bib0005","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.clinme.2025.100541_bib0006","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1172\/JCI60324","article-title":"Pathogenesis of chronic obstructive pulmonary disease","volume":"122","author":"Tuder","year":"2012","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.clinme.2025.100541_bib0007","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00128008","article-title":"Systemic manifestations and comorbidities of COPD","volume":"33","author":"Barnes","year":"2009","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.clinme.2025.100541_bib0008","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10654-006-9066-1","article-title":"Chronic obstructive pulmonary disease severity and cardiovascular outcomes","volume":"21","author":"Curkendall","year":"2006","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.clinme.2025.100541_bib0009","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40169-015-0068-z","article-title":"Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer","volume":"4","author":"King","year":"2015","journal-title":"Clin Transl Med"},{"issue":"6","key":"10.1016\/j.clinme.2025.100541_bib0010","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter-2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"6","key":"10.1016\/j.clinme.2025.100541_bib0011","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.ekir.2024.02.1435","article-title":"Narrative review of immunomodulatory and anti-inflammatory effects of sodium-glucose cotransporter 2 inhibitors: unveiling novel therapeutic frontiers","volume":"9","author":"Lee","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.clinme.2025.100541_bib0012","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bcp.2018.03.013","article-title":"Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells","volume":"152","author":"Xu","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clinme.2025.100541_bib0013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2022.03.005","article-title":"Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: evidence for potential off-target effects","volume":"167","author":"Dyck","year":"2022","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.clinme.2025.100541_bib0014","doi-asserted-by":"crossref","first-page":"82","DOI":"10.36628\/ijhf.2022.0030","article-title":"SGLT-2 inhibitors in heart failure: a review of current evidence","volume":"5","author":"Talha","year":"2023","journal-title":"Int J Heart Fail"},{"issue":"1176","key":"10.1016\/j.clinme.2025.100541_bib0015","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/postmj\/qgad022","article-title":"The use of sodium-glucose co-transporter-2 inhibitors in heart failure with reduced or preserved ejection fraction: new guidelines hot off the press and directly into guidelines!","volume":"99","author":"Clark","year":"2023","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clinme.2025.100541_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108861","article-title":"Cardiovascular therapeutic targets of sodium-glucose co-transporter-2 (SGLT2) inhibitors beyond heart failure","volume":"270","author":"Armillotta","year":"2025","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.clinme.2025.100541_bib0017","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamainternmed.2024.7811","article-title":"Glucose-lowering medications and risk of chronic obstructive pulmonary disease exacerbations in patients with type 2 diabetes","volume":"185","author":"Ray","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.clinme.2025.100541_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2025.101646","article-title":"Impact of SGLT-2i on COPD exacerbations in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"51","author":"Satapathy","year":"2025","journal-title":"Diab Metab"},{"issue":"6","key":"10.1016\/j.clinme.2025.100541_bib0019","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1513\/AnnalsATS.202407-703OC","article-title":"SGLT-2 inhibitors and the risk of chronic obstructive pulmonary disease exacerbations and mortality in chronic obstructive pulmonary disease patients","volume":"22","author":"Yen","year":"2025","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"10.1016\/j.clinme.2025.100541_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.30754","article-title":"Time to benefit of sodium-glucose cotransporter-2 inhibitors among patients with heart failure","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.clinme.2025.100541_bib0021","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/jamacardio.2022.3750","article-title":"Time to clinical benefit of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction: a prespecified secondary analysis of the DELIVER randomized clinical trial","volume":"7","author":"Vaduganathan","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.clinme.2025.100541_bib0022","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-017-0258-5","article-title":"Early effects of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring","volume":"9","author":"Torimoto","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.clinme.2025.100541_bib0023","author":"Core Team","year":"2025","journal-title":"R: A Language and Environment for Statistical Computing"},{"issue":"1","key":"10.1016\/j.clinme.2025.100541_bib0024","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1183\/09031936.00194610","article-title":"Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study","volume":"39","author":"Jenkins","year":"2012","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.clinme.2025.100541_bib0025","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/S2213-2600(24)00413-2","article-title":"GOLD COPD report: 2025 update","volume":"13","author":"Venkatesan","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"14","key":"10.1016\/j.clinme.2025.100541_bib0026","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2020.1906","article-title":"Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes","volume":"323","author":"Petrie","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clinme.2025.100541_bib0027","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12931-018-0951-4","article-title":"Clinical variables predicting the risk of a hospital stay for longer than 7\u2009days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study","volume":"19","author":"Crisafulli","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.clinme.2025.100541_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107819","article-title":"Use of Sodium-glucose co-transporter-2 (SGLT 2) inhibitor is associated with reduced emergency room visits and hospitalizations in patients with chronic obstructive pulmonary disease (COPD) and type 2 diabetes mellitus","volume":"234","author":"Shanmugavel Geetha","year":"2024","journal-title":"Respir Med"},{"key":"10.1016\/j.clinme.2025.100541_bib0029","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.hrtlng.2024.07.003","article-title":"The role of sodium-glucose transporter-2 inhibitors (SGLT-2i) in preventing chronic obstructive disease exacerbation in patients with diabetes and COPD: an electronic health database analysis","volume":"68","author":"Gupta","year":"2024","journal-title":"Heart Lung"},{"key":"10.1016\/j.clinme.2025.100541_bib0030","doi-asserted-by":"crossref","DOI":"10.1177\/17534666251363307","article-title":"Impact of influenza on chronic obstructive pulmonary disease: pathophysiology, exacerbations, and preventive approaches","volume":"19","author":"Mao","year":"2025","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.clinme.2025.100541_bib0031","article-title":"Relationship of body mass index on activities of daily living in hospitalized patients with chronic obstructive pulmonary disease","volume":"81","author":"Tomohara-Ichishima","year":"2022","journal-title":"Respir Med Res"},{"issue":"5","key":"10.1016\/j.clinme.2025.100541_bib0032","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S2213-2600(21)00506-3","article-title":"Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment","volume":"10","author":"Yang","year":"2022","journal-title":"Lancet Respir Med"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211825002593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211825002593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:37:24Z","timestamp":1769161044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211825002593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1470211825002593"],"URL":"https:\/\/doi.org\/10.1016\/j.clinme.2025.100541","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical effective of sodium\/glucose co-transporter-2 inhibitors on admission frequency, duration and use of acute non-invasive ventilation in patients with chronic obstructive pulmonary disease: A single-centre 24-month retrospective observational study in a UK tertiary care centre","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinme.2025.100541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Royal College of Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100541"}}